Why do ADHD medications interact with antidepressants or mood stabilisers?

PostedNovember 20, 2025

UpdatedNovember 21, 2025

ByMy Patient Advice

Author: Harriet Winslow, BSc | Reviewed by: Dr. Rebecca Fernandez, MBBS

Many people with ADHD are also treated for depression, anxiety, or bipolar disorder, which means combinations of ADHD medications and mood treatments are common. According to RCPsych, coexisting conditions are frequent in adults, so understanding how medicines interact is important for safe prescribing. These interactions usually relate to how the medicines affect brain chemicals like serotonin, dopamine, and noradrenaline, and how they are metabolised in the body.

Understanding why interactions occur

Guidance from NICE NG87 explains that stimulants such as methylphenidate and lisdexamfetamine increase dopamine and noradrenaline activity, while antidepressants like SSRIs and SNRIs increase serotonin. Because these systems overlap, the combination can raise the risk of side effects if doses are not carefully adjusted. Research shown in BMJ Mental Health highlights how altered neurotransmitter levels can influence mood stability, agitation, and cardiovascular responses.

Serotonin and cardiovascular risks

Information from NHS Shared Care guidance notes that using stimulants with SSRIs or SNRIs may increase serotonin levels, which can very rarely contribute to serotonin syndrome. The same guidance explains that stimulants and atomoxetine can influence blood pressure and heart rate, and this risk may increase when combined with antidepressants that also affect cardiovascular function. These effects are usually manageable in routine practice but require monitoring.

How metabolism affects interactions

Stimulants and antidepressants also interact because of how they are broken down. According to NHS prescribing guidelines, atomoxetine is metabolised by the CYP2D6 enzyme. Medicines like fluoxetine and paroxetine block this enzyme, which can raise atomoxetine levels and increase side effects. Some mood stabilisers may also interact through hepatic metabolism or electrolyte changes, which requires caution.

Safe combinations and clinical monitoring

Evidence from JAMA Network shows that many combinations, such as SSRIs with methylphenidate, can be safe when clinicians monitor blood pressure, mood changes and cardiovascular symptoms. NICE and RCPsych emphasise regular reviews, careful titration and attention to signs of agitation or manic symptoms when multiple medicines are used together.

Key takeaway

ADHD medications can interact with antidepressants or mood stabilisers because they affect shared neurotransmitter pathways and metabolic processes. With structured monitoring and guidance, most combinations can be used safely to support people who live with both ADHD and mood-related conditions.

Harriet Winslow, BSc

Author

Harriet Winslow is a clinical psychologist with a Bachelor’s in Clinical Psychology and extensive experience in behaviour therapy and developmental disorders. She has worked with children and adolescents with ADHD, autism spectrum disorder (ASD), learning disabilities, and behavioural challenges, providing individual and group therapy using evidence-based approaches such as CBT and DBT. Dr. Winslow has developed and implemented personalised treatment plans, conducted formal and informal assessments, and delivered crisis intervention for clients in need of urgent mental health care. Her expertise spans assessment, treatment planning, and behavioural intervention for both neurodevelopmental and mental health conditions.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy.

Dr. Rebecca Fernandez, MBBS

Reviewer

Dr. Rebecca Fernandez is a UK-trained physician with an MBBS and experience in general surgery, cardiology, internal medicine, gynecology, intensive care, and emergency medicine. She has managed critically ill patients, stabilised acute trauma cases, and provided comprehensive inpatient and outpatient care. In psychiatry, Dr. Fernandez has worked with psychotic, mood, anxiety, and substance use disorders, applying evidence-based approaches such as CBT, ACT, and mindfulness-based therapies. Her skills span patient assessment, treatment planning, and the integration of digital health solutions to support mental well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewer's privacy.